E-Mail
IMAGE: Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test from a. view more
Credit: Trevor J. Pugh
Philadelphia, January 21, 2021 - Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test from a small sample of DNA in colon, endometrial, and other cancers. This alternative to complex, multi-step testing workflows can also determine causes of MMR deficiency often missed by current clinical tests. Their results are presented in the
Oncologist Herbert Loong Joins George Clinical Scientific Leadership
News provided by
Share this article
Share this article
OVERLAND PARK, Kan., Jan. 18, 2021 /PRNewswire/ Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.
Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical oncology and Deputy Medical Director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.
Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Brazil weighs COVID-19 vaccines as its death toll climbs Brazil’s health regulatory agency Anvisa has yet to approve a vaccine, but the directors are expected to meet this Sunday to vote on both the CoronaVac and AstraZeneca vaccines.
Listen to the story.
Amazonas Federal University s workers carry empty oxygen tanks at the Getulio Vargas Hospital amid the new coronavirus pandemic, Manaus, Brazil, Thursday, Jan. 14, 2021. Scores of COVID-19 patients in the Amazon rainforest s biggest city will be transferred out of state as the local health system collapses and dwindling stocks of oxygen tanks begin to falter. Credit:
Share
Brazilian army general and Health Minister Eduardo Pazuello told Brazilian mayors in a meeting Thursday that his government plans to begin vaccinating people on Jan. 20, if the CoronaVac and AstraZeneca vaccines are approved by then.
Home / Top News / Young Investigators awarded $200k to study innovative new ways to engage the body’s immune system to fight lung cancer
Young Investigators awarded $200k to study innovative new ways to engage the body’s immune system to fight lung cancer
Lung Cancer Foundation of America, International Lung Cancer Foundation (ILCF) fund two new Young Investigator grants
Adrian Sacher, M.D., Thoracic Oncologist at the Princess Margaret Cancer Centre at the University of Toronto
Vincent K. Lam, M.D., Assistant Professor of Oncology at Johns Hopkins
Los Angeles, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the International Lung Cancer Foundation, and generously funded in part by Bristol-Myers Squibb, are investigating ways to harness the body’s powerful immune system to better treat lung cancer.